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Background
Lassa fever is an acute viral hemorrhagic fever caused by
the Lassa virus. It infects 300,000 to 500,000 West Africans
every year, with a mortality rate among hospitalized
patients of 15%. It is difficult to diagnose because its early
symptoms (fever, sore throat, general malaise) often go
unnoticed, or are confused with those of the common flu,
malaria, or other febrile diseases. For this reason, there is
considerable interest in developing tests that can detect the
presence of the virus at the earliest stages of infection,
when treatment is most effective. Methods such as
the enzyme-linked immunosorbent assay (ELISA) or the
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Figure 1 Expression patterns of 150 significant genes throughout Lassa and flu infection, using their pre-infection samples as baseline. Genes are
colored based on the Lassa cluster they belong to. The majority of genes follow a similar pattern in both types of infection, with the exception
of those in the green and red clusters.
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real-time polymerase chain reaction (RT-PCR) are com-
monly used to detect virus particles in the blood, but in the
case of Lassa, when the infection becomes detectable, it is
already too late to administer treatment.
In this study, we took an indirect approach and analyzed
the transcriptional response of the circulating immune
system, instead of directly measuring the amount of virus
in the blood, to see if we could detect earlier signs of infec-
tion. We extracted samples of peripheral blood mononuc-
lear cells from infected non-human primates at sequential
timepoints for a period of 12 days. The RNA in each sam-
ple was assayed in a microarray to quantify the transcrip-
tional pattern followed by each gene throughout the
infection. We used these patterns to identify genes with
the strong transcriptional changes 3 days after infection,
since these have the greatest chance of being biologically
significant, and could be used as early biomarkers of
infection.
Results
Out of the ~150 genes that we identified as differentially
expressed, many haven’t been described to play any signifi-
cant role in immunity, but others involved in the JAK-
STAT and the interferon pathways are well known regula-
tors of the antiviral response. To further limit our list of
candidate biomarkers, we compared it with another set of
genes obtained from a similar experiment conducted on
patients that were infected with the common flu [1]. This
allowed us to remove genes that showed similar patterns
of expression in both diseases, indicating that they have lit-
tle discriminative power, and keep those that were charac-
teristic of Lassa virus infection (Figure [1] ).
Conclusions
We are in the process of acquiring additional samples to
validate the specificity and sensitivity of our biomarker,
with the medium-term goal of applying it in a clinical set-
ting. We believe we have identified a gene signature that
could potentially diagnose Lassa fever infection in patients
before they show specific clinical symptoms, an essential
requirement in treatment and prevention.
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